AGILE THERAPEUTICS INC's ticker is AGRX and the CUSIP is 00847L100. A total of 53 filers reported holding AGILE THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $61,000 | -57.0% | 290,345 | 0.0% | 0.00% | – |
Q4 2021 | $142,000 | -49.1% | 290,345 | 0.0% | 0.00% | – |
Q3 2021 | $279,000 | -27.7% | 290,345 | 0.0% | 0.00% | – |
Q2 2021 | $386,000 | -82.8% | 290,345 | -73.1% | 0.00% | – |
Q1 2021 | $2,242,000 | -32.2% | 1,077,910 | -6.5% | 0.00% | – |
Q4 2020 | $3,307,000 | +1.3% | 1,152,380 | +7.4% | 0.00% | – |
Q3 2020 | $3,263,000 | +12.1% | 1,073,383 | +2.5% | 0.00% | – |
Q2 2020 | $2,911,000 | +3170.8% | 1,047,165 | +2090.7% | 0.00% | – |
Q1 2020 | $89,000 | -82.6% | 47,800 | -69.9% | 0.00% | – |
Q1 2017 | $512,000 | -36.9% | 158,642 | +11.4% | 0.00% | – |
Q4 2016 | $811,000 | -16.9% | 142,442 | +2.0% | 0.00% | – |
Q3 2016 | $976,000 | -3.8% | 139,618 | +4.6% | 0.00% | – |
Q2 2016 | $1,015,000 | +64.5% | 133,438 | +34.2% | 0.00% | – |
Q1 2016 | $617,000 | -21.0% | 99,405 | +24.4% | 0.00% | – |
Q4 2015 | $781,000 | +42.0% | 79,923 | -2.1% | 0.00% | – |
Q3 2015 | $550,000 | +5.4% | 81,642 | +34.1% | 0.00% | – |
Q2 2015 | $522,000 | – | 60,878 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 31,839,850 | $42,348,000 | 0.28% |
NEEDHAM INVESTMENT MANAGEMENT LLC | 735,000 | $978,000 | 0.14% |
INVESTOR AB | 3,510,189 | $4,669,000 | 0.14% |
Tibra Equities Europe Ltd | 241,100 | $321,000 | 0.10% |
FIRST MIDWEST BANK TRUST DIVISION | 349,158 | $464,000 | 0.06% |
GSA CAPITAL PARTNERS LLP | 372,543 | $495,000 | 0.06% |
DUMONT & BLAKE INVESTMENT ADVISORS LLC | 110,000 | $146,000 | 0.04% |
Kalos Management, Inc. | 19,250 | $24,000 | 0.01% |
Summit Global Investments | 110,100 | $146,000 | 0.01% |
Founders Capital Management | 10,000 | $13,000 | 0.01% |